>> Ideally you would want to know why each person
does well, and when they outperform. <<
Exactly. A team of cooperating investors, pooling talents and research with the goal of insight, not just knowledge.
>> I hunkered down in microcap
biotechs <<
Your timing last Fall was great. It was fun to watch. Since then, some of your microcaps have threatened to become noncaps. It would be good to see things reverse for some of them.
>> I wish I could say buy Peter and Rick's top two picks--but
I don't really know these guys, we know they're brutally
honest on these threads, so that is good, but in general
you don't want to go around buying what others recommend
"do your own DD" is the cliche. <<
Yup. However, I've been making my calls very public since Spring '95, and I deserve respect for what I've accomplished. Certainly, Peter was remarkable in '98, and seems to be doing just fine in '99. But your point is clear...... my picks on Monday and going forward could be rotten.
>> I think there is one thing we do know--that the biotech
mutual funds are probably not the way to go. <<
The collective efforts here at SI constitute the world's best biotech research. Some threads for good companies are weak. Some threads for lousy companies have lots of noise, but no data to speak of. The remainder of threads..... the quiet ones for good companies and the noisy ones with lots of data...... those are the ones where the profits will be uncovered.
Again, a review of the Agouron and -- now -- Sugen threads, start to finish, will help the newbies and vets alike.
Thanks, Mike.
Rick |
